Apellis Pharmaceuticals
APLS
$49.86
Share price
4.03%
Change (1 day)
-39.77%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) - Cash on Hand
Cash on Hand as of December 2023 : $0.35 B
According to Apellis Pharmaceuticals's latest financial reports the company has $0.35 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Apellis Pharmaceuticals - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.35 B | -36.36% |
| 2022-12-31 | $0.55 B | -21.23% |
| 2021-12-31 | $0.70 B | -20.18% |
| 2020-12-31 | $0.87 B | 149.34% |
| 2019-12-31 | $0.35 B | 99.69% |
| 2018-12-31 | $0.17 B | 0.36% |
| 2017-12-31 | $0.17 B | 606.43% |
| 2016-12-31 | $24.86 M | -30.94% |
| 2015-12-31 | $36 M | 164.29% |
| 2014-12-31 | $13.62 M | 186.3% |
| 2013-12-31 | $4.75 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -40.72% | 🇺🇸 USA |